Generate a tailored SOP for Dr. Barbara Pro. Improve your application with a focused, well-structured draft.
Dr. Barbara Pro is a distinguished professor of medicine at Columbia University Vagelos College of Physicians and Surgeons, where she also serves as the clinical director of the lymphoma program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian/Columbia. Her expertise lies in the clinical practice and research of T-cell lymphoma, a rare form of non-Hodgkin lymphoma. She is widely recognized for her significant contributions to drug development for Hodgkin and non-Hodgkin lymphomas and has led multi-center clinical trials evaluating new targeted therapies for patients with aggressive lymphoma subtypes, culminating in FDA approvals of novel agents. With over 150 peer-reviewed research articles published in prestigious journals such as the Journal of Clinical Oncology, Blood, and The Lancet, Dr. Pro is a highly respected figure in her field. Before her tenure at Columbia, she was the clinical director of the lymphoma program and the director of the hematology oncology fellowship program at the Robert H. Lurie Comprehensive Cancer Center. Dr. Pro has received numerous awards and is an active member of various professional organizations, including the American Society of Hematology and the American Society of Clinical Oncology.
Columbia University Vagelos College of Physicians and Surgeons • New York, NY
Professor of Medicine, Clinical Director of Lymphoma Program
PhD programs at VP&S are often administered through the Coordinated Doctoral Programs in Biomedical Sciences (Integrated Program).